Literature DB >> 1533858

Comparison of the development of tolerance to nitroglycerin in aortic preparations isolated from non-diabetic and diabetic rats.

T Matsuzaki1, M Sakanashi.   

Abstract

To clarify whether or not tolerance to nitroglycerin is developed more easily in a diabetic than in a non-diabetic state, the effects of nitroglycerin on aortic preparations isolated from diabetic and non-diabetic rats were examined and compared with those of nicorandil, which has been known to develop less tolerance than does nitroglycerin. Contractile responses to norepinephrine, relaxant responses to nitroglycerin and nicorandil, and the tolerance development to nitroglycerin were found to be no different between diabetic and non-diabetic aortic preparations. N-Acetylcysteine preincubated together with nitroglycerin prevented the tolerance development to nitroglycerin in non-diabetic but not in diabetic aortic preparations. The results suggest that the tolerance to nitroglycerin is developed in the diabetic as well as in the non-diabetic state.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533858     DOI: 10.1007/bf01745861

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  26 in total

1.  On the enzymatic determination of blood glucose.

Authors:  E RAABO; T C TERKILDSEN
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

2.  Mechanisms of nitrate-induced vasodilatation and tolerance on a biochemical base.

Authors:  W R Kukovetz; S Holzmann
Journal:  Z Kardiol       Date:  1985

3.  Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.

Authors:  M D Winniford; P L Kennedy; P J Wells; L D Hillis
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

4.  Cyclic GMP in nicorandil-induced vasodilatation and tolerance development.

Authors:  W R Kukovetz; S Holzmann
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

Review 5.  Actions of nicorandil on vascular smooth muscles.

Authors:  K Sumimoto; M Domae; K Yamanaka; K Nakao; T Hashimoto; K Kitamura; H Kuriyama
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

6.  Tolerance to organic nitrates.

Authors:  J Abrams
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690

7.  Mechanism of tolerance development to organic nitrates.

Authors:  P Needleman; E M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

8.  Intracellular delivery of cysteine.

Authors:  M E Anderson; A Meister
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

9.  Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

Authors:  J Torresi; J D Horowitz; G J Dusting
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

10.  Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin-induced diabetes.

Authors:  D Loven; H Schedl; H Wilson; T T Daabees; L D Stegink; M Diekus; L Oberley
Journal:  Diabetes       Date:  1986-05       Impact factor: 9.461

View more
  3 in total

1.  Effects of N-acetylcysteine on nitroglycerin-induced relaxation and protein phosphorylation of porcine coronary arteries.

Authors:  Y Tate; K Kawasaki; S Ishibashi; U Ikeda; K Shimada
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Diminished paracrine regulation of the epithelial Na+ channel by purinergic signaling in mice lacking connexin 30.

Authors:  Elena Mironova; Janos Peti-Peterdi; Vladislav Bugaj; James D Stockand
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

3.  Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats.

Authors:  P Murray; B Pitt; R C Webb
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.